Noradrenalin
Recall
|
Medicines
|
01/04/2016
The pharmaceutical company "Amomed Pharma GmbH" has informed its supplied customers by letter dated 11.03.2016 that in the course of stability testing a clear brown coloration of the solution was detected in some ampoules. This brown coloration results from a production deviation and occurs after longer storage at room temperature.
| Name of the medicinal product | Noradrenalin Orpha 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung |
|---|---|
| Marketing authorisation number(s) | 1-31880 |
| Marketing authorisation holder | Orpha-Devel Handels und Vertriebs GmbH Durchführung Rückruf: Amomed Pharma GmbH |
| Batch number(s) | 5A631A, 5A632A, 5A633A |
| Classification of the recall | 2 |
| BASG reference number | INS - 640.001 - 1 679 |
Further inquiry note
Page last modified:
12/07/2022